Telix Pharmaceuticals Limited (TLX)
NASDAQ: TLX · Real-Time Price · USD
7.39
-0.13 (-1.73%)
Mar 9, 2026, 2:16 PM EDT - Market open
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of $2.42 billion as of March 9, 2026. Its market cap has decreased by -63.50% in one year.
Market Cap
2.42B
Enterprise Value
2.77B
1-Year Change
-63.50%
Ranking
Category
Stock Price
$7.39
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from $115.28M to $2.42B, an increase of 2,003.28%. That is a compound annual growth rate of 44.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dianthus Therapeutics | 2.82B |
| Vera Therapeutics | 2.79B |
| Arcus Biosciences | 2.77B |
| Beam Therapeutics | 2.64B |
| Apellis Pharmaceuticals | 2.57B |
| Travere Therapeutics | 2.51B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |